Sawai today for
a healthier tomorrow.

We are a generic pharmaceutical company dedicated to lowering cost
and providing solutions for patients in need around the world.

ABOUT US

We Are
SAWAI

Here’s a quick glance at Sawai.
Learn about who we are and what we are doing for you.

Stock
Quotes

Stock Quotes

View More Stock Information

Financials

Financial Highlights

Cash Flow

Per Share Information

Other

Latest
IR Reports

Latest IR Reports

Nov. 09. 2020

FY2020 Financial Results for the 1st Half

Nov. 09. 2020

Summary of Financial Results for the 1st Half of FY 2020

Nov. 11. 2020

Current Status of The U.S. Business

Nov. 16. 2020

FY2020 Financial Results for the 1st Half（Webcast）

Nov. 27. 2020

Notice of the Extraordinary General Meeting of Shareholders

Learn More

Transparency
Sustainability

Our Commitment
to Transparency

To ensure we create a relationship with our consumers, we are transparent with all of our inner workings in order to push innovation by working with all of our stakeholders.

View All

Sustainability
Initiatives

We will contribute to the realization of an environmentally responsible society through our application of sustainable business practices and our role in the further development of a superior healthcare system.

View All

Latest News

Feb. 15. 2021

Sawai Receives Approvals for Eight Generic Drugs with 20 Strengths

Feb. 12. 2021

Sawai Reports Third Quarter FY2020 Financial Results

Jan. 28. 2021

Sawai and Neurolief enter into Exclusive Development and Marketing Agreement for Relivion

Dec. 16. 2020

Upsher-Smith Launches Ramelteon Tablets

Dec. 10. 2020

Sawai Launches Two Generic Drugs with 10 Strengths

Learn More

Integrated
report

Integrated
Report

Integrated Report
[ Year Ended March 31, 2020 ]

Integrated Report

Financial Section

Integrated Report
[ Year Ended March 31, 2020 ]

Sawai today for a healthier tomorrow.